Skip Navigation
CNBC
Markets
  • Pre-Markets
  • U.S. Markets
  • Europe Markets
  • China Markets
  • Asia Markets
  • World Markets
  • Currencies
  • Prediction Markets
  • Cryptocurrency
  • Futures & Commodities
  • Bonds
  • Funds & ETFs
Business
  • Economy
  • Finance
  • Health & Science
  • Media
  • Real Estate
  • Energy
  • Climate
  • Transportation
  • Investigations
  • Industrials
  • Retail
  • Wealth
  • Sports
  • Life
  • Small Business
Investing
  • Personal Finance
  • Fintech
  • Financial Advisors
  • Options Action
  • ETF Street
  • Buffett Archive
  • Earnings
  • Trader Talk
Tech
  • Cybersecurity
  • AI
  • Enterprise
  • Internet
  • Media
  • Mobile
  • Social Media
  • CNBC Disruptor 50
  • Tech Guide
Politics
  • White House
  • Policy
  • Defense
  • Congress
  • Expanding Opportunity
  • Europe Politics
  • China Politics
  • Asia Politics
  • World Politics
Video
  • Latest Video
  • Full Episodes
  • Livestream
  • Top Video
  • Live Audio
  • Europe TV
  • Asia TV
  • CNBC Podcasts
  • CEO Interviews
  • Digital Originals
Watchlist
Investing Club
  • Trust Portfolio
  • Analysis
  • Trade Alerts
  • Meeting Videos
  • Homestretch
  • Jim's Columns
  • Education
  • Subscribe
Join IC
PRO
  • Pro News
  • Josh Brown
  • Mike Santoli
  • Calls of the Day
  • My Portfolio
  • Livestream
  • Full Episodes
  • Stock Screener
  • Market Forecast
  • Options Investing
  • Chart Investing
  • Subscribe
Join Pro
Livestream
  • Make It
  • select
  • USA
  • INTL
  • Livestream
  • Livestream
Watchlist
SIGN IN
Create free account
Markets
Business
Investing
Tech
Politics
Video
Watchlist
Investing Club
Join IC
PRO
Join Pro
Livestream

Business News

Medicine

Cleveland Cavaliers owner Dan Gilbert turns grief over son’s rare disease into search for a cure
Cleveland Cavaliers owner Dan Gilbert turns grief over son’s rare disease into search for a cure
Brad QuickThu, May 28th 2026
Why J&J thinks its new psoriasis pill could be one of its biggest drugs ever
Why J&J thinks its new psoriasis pill could be one of its biggest drugs ever
Natasha AbellardSat, May 16th 2026
Rare disease families find roadmap to drug development at bootcamps
Rare disease families find roadmap to drug development at bootcamps
Ryan AnastasioThu, May 7th 2026
watch now
Here are some of the companies working on new heart attack prevention drugs
Here are some of the companies working on new heart attack prevention drugs
Angelica PeeblesMon, Apr 27th 2026
Regeneron weighs overseas price for gene therapy for rare type of hearing loss
Regeneron weighs overseas price for gene therapy for rare type of hearing loss
Angelica PeeblesFri, Apr 24th 2026
watch now
Clean energy executive returns to Boston Marathon after rare disease left her partially paralyzed
watch now
VIDEO02:04
CNBC Cures
Clean energy executive returns to Boston Marathon after rare disease left her partially paralyzed
Mon, Apr 20th 2026
Naomi Watts' menopause message: 'Why is it so taboo when we are half population'
CNBC Changemakers
Naomi Watts' menopause message: 'Why is it so taboo when we are half population'
Sat, Apr 18th 2026
watch now
Dr. Angela Fitch on GLP-1 mental health concerns: Data shows patients' moods get better, not worse
watch now
VIDEO05:39
Squawk Box
Dr. Angela Fitch on GLP-1 mental health concerns: Data shows patients' moods get better, not worse
Fri, Apr 17th 2026
Money Movers
What to know about Revolution Medicines' pancreatic cancer pill testing
Fri, Apr 10th 2026
CNBC Cures
CNBC Cures: A doctor dad on how raising child with Angelman syndrome changed him
Thu, Apr 9th 2026
CNBC Cures
How CNBC Cures is bringing rare disease stories to a national audience
Fri, Mar 20th 2026

Trending Now

  • 1
    Sellers are pulling homes off the market at the fastest pace since 2020
  • 2
    Why we're raising our price target on Broadcom despite its post-earnings sell-off
  • 3
    Highly successful people use 5 phrases to disagree with their bosses: You’ll ‘earn their respect and trust,’ says expert
  • 4
    Broadcom stock plunges on weak software sales, unchanged AI chip forecast for the year
  • 5
    CrowdStrike is a buy, just not yet. Here's why

More In Medicine

watch now
How families are defying rare disease | CNBC Full Documentary
watch now
VIDEO42:59
CNBC Cures: Defying Rare Disease
How families are defying rare disease | CNBC Full Documentary
Mon, Apr 20th 2026
watch now
India's weight-loss drug boom: Novo Nordisk on generics in the GLP-1 market
watch now
VIDEO03:55
Inside India
India's weight-loss drug boom: Novo Nordisk on generics in the GLP-1 market
Fri, Mar 20th 2026
Strait of Hormuz standoff puts supply of generic drug prescriptions at risk
The Bottom Line
Strait of Hormuz standoff puts supply of generic drug prescriptions at risk
Tue, Mar 17th 2026
CNBC Cures
Decades into cystic fibrosis fight, Boomer Esiason and son Gunnar are winning
Wed, Mar 4th 2026
CNBC Cures
FDA watchers warn of agency in 'chaos' and risk to America's health
Wed, Mar 4th 2026
Politics
Epstein files: Nobel winner quits Columbia U. brain institute
Wed, Feb 25th 2026
Sumitomo Pharma shares plunge nearly 16% despite greenlight for Parkinson's treatment
Markets
Sumitomo Pharma shares plunge nearly 16% despite greenlight for Parkinson's treatment
Fri, Feb 20th 2026
How largest health-care education company in U.S. is tackling growing jobs gap
Leadership Insights
How largest health-care education company in U.S. is tackling growing jobs gap
Wed, Feb 11th 2026
Cigna settles FTC insulin case, commits to overhauling drug pricing
Health and Science
Cigna settles FTC insulin case, commits to overhauling drug pricing
Wed, Feb 4th 2026
Health and Science
FDA requests removal of suicide warnings from weight-loss drugs
Tue, Jan 13th 2026
Power Lunch
Obesity pill race heats up
Thu, Dec 18th 2025
CNBC Investigations
U.S. employer health plans tap prescriptions that feds say are illegal
Fri, Nov 14th 2025
watch now
OpenEvidence founder: Medical AI shows that our nation's investment is paying dividends
watch now
VIDEO05:44
Squawk on the Street
OpenEvidence founder: Medical AI shows that our nation's investment is paying dividends
Tue, Nov 11th 2025
watch now
Latest read on first-in-disease therapy from Insmed CEO Will Lewis
watch now
VIDEO05:01
Fast Money
Latest read on first-in-disease therapy from Insmed CEO Will Lewis
Mon, Nov 3rd 2025
Nobel medicine prize goes to researchers into immune system precision
Health and Science
Nobel medicine prize goes to researchers into immune system precision
Mon, Oct 6th 2025
Squawk Box
Dr. Richard Frye: Leucovorin is not 'a cure', but 'one tool' we have for autism
Thu, Oct 2nd 2025
Economy
Trump tariff threat looms over robotics and medical devices in sweeping probe
Thu, Sep 25th 2025
Biotech and Pharma
UniQure's therapy slows Huntington's disease progression in trial
Wed, Sep 24th 2025
watch now
How China's aging population is powering a consumer health care boom
watch now
VIDEO05:57
Squawk Box Asia
How China's aging population is powering a consumer health care boom
Thu, Sep 18th 2025
Lutnick says update coming this week on Japan's $550 billion U.S. investment
Trade
Lutnick says update coming this week on Japan's $550 billion U.S. investment
Tue, Aug 26th 2025
watch now
Leerink's Risinger on Eli Lilly downgrade: Triggered by disappointing obesity pill results
watch now
VIDEO04:21
Power Lunch
Leerink's Risinger on Eli Lilly downgrade: Triggered by disappointing obesity pill results
Thu, Aug 7th 2025
Space
Space startup Varda raises $187 million in funding to make drugs in orbit
Thu, Jul 10th 2025
Health and Science
U.S. physician groups sue Kennedy over vaccine policy
Tue, Jul 8th 2025
Power Lunch
Hims & Hers: Here are the risks with the stock after Novo Nordisk terminated its partnership
Tue, Jun 24th 2025
CNBC logo
  • Subscribe to CNBC PRO
  • Subscribe to Investing Club
  • Licensing & Reprints
  • CNBC Councils
  • Join the CNBC Panel
  • Digital Products
  • News Releases
  • Closed Captioning
  • Corrections
  • About CNBC
  • Internships
  • Site Map
  • Careers
  • Help
  • Contact
  • News Tips

    Got a confidential news tip? We want to hear from you.

    Get In Touch
  • CNBC Newsletters

    Sign up for free newsletters and get more CNBC delivered to your inbox

    Sign Up Now

    Get this delivered to your inbox, and more info about our products and services.

  • Advertise With Us

    Please Contact Us
  • Ad Choices
  • Privacy Policy
  • California Consumer Privacy Act (CCPA) Opt-Out IconYour Privacy Choices
  • CA Notice
  • Terms of Service

© 2026 Versant Media, LLC. All Rights Reserved. A Versant Media Company.

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided byReuters logo